A Cell-Delivered and –Activated SN38-Dextran Prodrug Increases Survival in a Murine Disseminated Pancreatic Cancer Model

Enzyme activated prodrugs have been investigated and sought after as highly specific, low side effect treatments, especially for cancer therapy. Unfortunately, excellent targets for enzyme activated therapy are rare. Here we demonstrate a system based on cell delivery that can carry both a prodrug a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Basel, Matthew T., Balivada, Sivasai, Shrestha, Tej B., Seo, Gwi-Moon, Pyle, Marla M., Tamura, Masaaki, Bossmann, Stefan H., Troyer, Deryl L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3583224/
https://ncbi.nlm.nih.gov/pubmed/22238072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/smll.201101879
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados